Clinical Trial Update: Argatroban in Critically Ill Patients With Heparin Resistance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Argatroban for achieving sufficient thrombosis prophylaxis in critically ill patients with heparin resistance; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Heparin Resistance

Drugs mentioned

• Argatroban (argatroban)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance | Phase 2 | Status: COMPLETED